|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Gail_McIntyre
|
|
gptkbp:focusesOn
|
RNA medicines
therapeutics development
|
|
gptkbp:foundedIn
|
2022
|
|
gptkbp:founder
|
gptkb:Josh_Mandel-Brehm
gptkb:Vasudevan_Lakshminarayanan
gptkb:Vikas_Goyal
gptkb:Aviv_Regev
gptkb:David_Altshuler
gptkb:David_Bartel
gptkb:David_Page
gptkb:Eric_Lander
gptkb:Feng_Zhang
gptkb:Robert_Langer
gptkb:David_Liu
gptkb:John_Maraganore
gptkb:David_Sabatini
gptkb:David_Walt
gptkb:David_Berry
|
|
gptkbp:fundedBy
|
$270 million
|
|
gptkbp:headquartersLocation
|
gptkb:Cambridge,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Orbital Therapeutics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:investor
|
gptkb:Newpath_Partners
gptkb:Pivotal_bioVenture_Partners
gptkb:Platinum_Venture_Partners
gptkb:RA_Capital_Management
gptkb:Andreessen_Horowitz
gptkb:Foresite_Capital
gptkb:Arch_Venture_Partners
gptkb:Casdin_Capital
gptkb:Rock_Springs_Capital
gptkb:T._Rowe_Price
gptkb:Viking_Global_Investors
gptkb:Surveyor_Capital
|
|
gptkbp:notableEmployee
|
gptkb:Josh_Mandel-Brehm
gptkb:Vikas_Goyal
gptkb:Gail_McIntyre
gptkb:John_Maraganore
|
|
gptkbp:platform
|
RNA-based therapeutics
|
|
gptkbp:therapeuticArea
|
oncology
vaccines
rare diseases
immunomodulation
protein replacement
|
|
gptkbp:website
|
https://www.orbitaltx.com/
|
|
gptkbp:bfsParent
|
gptkb:John_Maraganore
|
|
gptkbp:bfsLayer
|
6
|